Oscar Insurance quits some exchange markets; CEO Mario Schlosser says they're not working

A signpost with the words Affordable Care Act

CREDIT: Getty/kroach

Oscar Insurance Corp., the health insurer branded as a tech firm that aimed to turn the industry on its head, will exit ACA markets in Dallas and New Jersey, according to Bloomberg.

Oscar is the latest insurer to withdraw from some markets, following in the footsteps of Aetna, UnitedHealth and Scott & White, which have all announced substantial reductions in their ACA exchange offerings.

Whitepaper

Key Realities Pushing Healthcare Into a Digital Future

Paper forms, contracts, and documents are the quicksand that bogs down both patient care and provider business. However, that does not have to be the case. Download this whitepaper to learn the three key realities that are pushing healthcare past paper-based processes and into a digital, more streamlined future.

“The individual market isn’t working as intended and there are weaknesses in the way its been set up,” CEO Mario Schlosser told Bloomberg. 

The user-experience driven, tech-savvy insurer suffered $83 million in losses during the first half of 2016, Bloomberg adds. CEO Mario Schlosser oversaw $92.4 million of losses in New York alone in 2015.

Just last month, Schlosser wrote in a blog post Oscar will slash its provider network almost 50 percent in some areas on top of a 16 percent premium hike in New York, but that the move was not entirely motivated by the company’s bottom line. The company, which raised $400 million earlier this year in an investment round lead by Fidelity, has sufficient venture capital backing to withstand lossess for several years, according to Bloomberg. 

 

The insurer did say, however, it plans to expand its ACA presence in the San Francisco Bay Area. “Some of this is really looking at our opportunities and trying to pursue more aggressively the small-group market,” Oscar’s chief policy and strategy officer Joel Klein told Bloomberg.

Oscar’s decision impacts 33,000 enrollees between the two markets, leaving 7,000 people covered in Dallas and 26,000 people covered in New Jersey, according to the report. 

- read the Bloomberg report

Suggested Articles

Specialty drugs made up 1% of prescriptions for employers but accounted for 40% of total drug spending last year, an analysis found.

A collaboration between California payers and providers yielded millions in savings and prevented thousands of unneeded ER visits and admissions. 

Physicians certified by the American Board of Internal Medicine will soon have a new option that takes some of the pain out of MOC.